EltaMD UV Clear Acne Blemish-Prone & Oil Balancing SPF 50










EltaMD UV Clear Acne Blemish-Prone & Oil Balancing SPF 50
EltaMD UV Clear Acne Blemish-Prone & Oil Balancing SPF 50 â Clearer Skin + High-Performance Daily Protection
Meet the sunscreen designed to do more than protect. EltaMD UV Clear Acne Blemish-Prone & Oil Balancing SPF 50 delivers advanced broad-spectrum defense while actively supporting clearer, calmer, more balanced skin. Created specifically for oily, breakout-prone, and sensitive complexions, this next-generation formula helps reduce visible blemishes, control shine, and refine the look of poresâwithout heaviness or irritation.
Powered by 5% niacinamide and innovative Zinc-AOX Pro Technology, this lightweight hybrid sunscreen helps strengthen the skin barrier while defending against UV damage and environmental stressors that can worsen breakouts and discoloration. The breathable texture disappears seamlessly into the skin, leaving a smooth, natural finish that layers beautifully under makeup or wears comfortably on its own.
Why Acne-Prone Skin Loves This Formula
Unlike traditional sunscreens that can feel greasy or clog pores, this dermatologist-trusted formula supports oil balance and skin clarity while delivering reliable daily SPF protectionâmaking it ideal for consistent, long-term use.
Key Benefits
- Provides high-level broad-spectrum SPF 50 protection against UVA and UVB damage
- Helps visibly reduce blemishes by up to 65% with continued use*
- Controls excess oil and shine for a more balanced complexion*
- Minimizes the appearance of pores for smoother-looking skin*
- Lightweight, breathable texture with a natural, transparent finish
- Layers easily under makeup without pilling
- Non-comedogenic, non-acnegenic, and fragrance-free
- Suitable for sensitive, oily, and blemish-prone skin
With daily use, skin looks clearer, more refined, and healthierâwhile staying protected from the sun exposure that can worsen breakouts and post-blemish marks. âď¸â¨
*Results based on a 12-week clinical study of 43 subjects.